Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
FARMINGTON, Conn., Nov. 28, 2012 /PRNewswire-iReach/ -- With the end of 2012 fast approaching, marketers and business development managers across the globe are turning to Global Information Inc (GII) and our partner publishers to help them determine what lines of business to pursue in 2013. Three significant new market research reports from our premium research partner Global Industry Analysts, Inc. offer vital forecasts for the global molecular diagnostics, regenerative medicine, and flow cytometry markets.
The first report examines the global market for molecular diagnostics with an emphasis on how to improve reimbursement for costly and esoteric personalized medicine products. Touted as the next-generation technology to revolutionize the medical care system of the future, a second report provides a comprehensive review of the regenerative medicine market. A third report explores how next generation point-of-care compact systems will drive growth in the global market for flow cytometry.
More details are available below, but parties interested in a more in-depth review of market trends and available research are encouraged to contact Global Information Inc directly at 1.860.674.8796, or online at www.giiresearch.com/contact.shtml
The global market for molecular diagnostics is forecast to exceed $10.7 billion by 2018. Recent advancements in molecular diagnostics include a shift towards near-patient testing practices, increasing number of innovative biomarkers, and an increased effort for clinically validating tests. In addition, the market is experiencing increasing competition, modifications in the regulatory environment, an improved role of personalized medicine, as well as consolidation within the area of molecular diagnostics.
Major players in the global marketplace include Abbott Laboratories, Life Technologies Corporation, bioMérieux, CytoCore Inc., ELITech Group, GE Healthcare, Genzyme Corp., Hologic Inc., Laboratory Corporation of America Holdings, MiraiBio Inc., Novartis Diagnostics, QIAGEN N.V, Quest Diagnostics Inc., Roche Diagnostics, Siemens Healthcare Diagnostics Inc., and Tecan Group Ltd.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138654-molecular-diagnostics.html
Driven by technological advances and favorable demographics, the global market for regenerative medicine is projected to exceed $4.4 billion by 2018. Potentially huge savings on the medical care front and enhanced healing capabilities of regenerative medicine are expected to be the major contributing factors for market growth. Supportive political actions, government funding, corporate investment, clinical outcomes, increased awareness, increased endorsement from doctors, enhanced manufacturing technologies, and novel sources of stem cells are also expected to impart momentum to the growth of regenerative medicine.
The orthopedics segment which includes spine, bone grafts and bone substitutes is the largest among the different fields of global regenerative medicine market. Advancements in the biological science has drastically revolutionized regenerative medicine domain. Specifically, regenerative medicine in bone and joint applications made huge strides over the past few years. Healthy growth in the bone and joint applications is primarily due to the ageing baby boomer population and escalating incidence of osteoporosis, arthritis, and several other bone and joint traumas, including knee injuries and hip fractures. Growing awareness among people for regenerative medicines and increasing usage of non-autograft products by doctors and medical personnel are also stimulating growth for these products.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138657-regenerative-medicine.html
Driven by the advent of technically advanced flow cytometers, enhanced fluorescent dyes, integration of multiplexing, imaging and other complementary technologies, the global market for flow cytometry is projected to reach $2.3 billion by 2018. The global flow cytometry market is highly concentrated with only two major companies dominating the market - Becton, Dickinson and Company, followed by Danaher/Beckman Coulter. Other leading players profiled in the study include Advanced Analytical Technologies, Inc., Amnis Corporation, Bangs Laboratories, Inc., Cytek Development, Inc., eBioscience, Inc., Life Technologies Corporation, Luminex Corp., Merck Millipore, and PointCare Technologies, Inc., among others.
Long-term growth in the flow cytometer market would stem from development of next generation, point-of-care, compact systems. In terms of sophistication, newer integrated systems are increasingly incorporating innovative features, functions, and applications. Newer instruments from leading players designed to meet the high productivity requirements of researchers feature sorting rates of up to 70,000 events/second. Several modern cytometers are equipped with varying fluorescence detectors and lasers, which enable labeling of multiple antibodies. A few recently launched instruments are also capable of taking digital images of individual cells. Despite the rapid growth forecast, lack of awareness is the main drawback for flow cytometers. Though a number of technologically advanced flow cytometers are available in the market, several end-users are still not aware of the upgraded versions.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go134614-flow-cytometers.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.